Matrix Metalloproteinase-2 Promoter Genotype as a Marker of Cutaneous T-Cell Lymphoma Early Stage

Warning

This publication doesn't include Faculty of Sports Studies. It includes Faculty of Medicine. Official publication website can be found on muni.cz.
Authors

VAŠKŮ Anna BIENERTOVÁ VAŠKŮ Julie MIROSLAV Nečas VAŠKŮ Vladimír

Year of publication 2010
Type Article in Periodical
Magazine / Source Journal of Biomedicine and Biotechnology
MU Faculty or unit

Faculty of Medicine

Citation
Field Dermatovenerology
Keywords cutaneous T-cell lymphoma; mycosis fungoides; matrix metalloproteinase 2; promoter; genotype
Description The aim of the study was to investigate the DNA polymorphic genotype in MMP2 promoter gene as a potential candidate region for the development of the cutaneous T cell lymphoma (CTCL) andor its progression. A total of 89 Czech patients with CTCL (including 23 patients with large plaque parapsoriasis) were compared to 198 controls. The three selected polymorphisms in the promoter of MMP2 gene were determined using the PCR based methodology with RFLP. In our cohort, the associated GGCCTT MMP2 promoter genotype was highly significantly more frequent in CTCL Ia stage patients compared to patients with parapsoriasis, the tests having high sensitivity and specificity (78%, 83%, resp.). To conclude, use of associated MMP2 promoter genotype as a DNA marker might make it possible to distinguish between the patients with parapsoriasis and those with CTCL stage Ia, which could substantially improve possibilities of clinical diagnostics, therapy design, and prognosis of this serious condition in the early stages.

You are running an old browser version. We recommend updating your browser to its latest version.

More info